NFKB1 and cancer: Importantly, NF-κB signalling pathway is commonly overly activated in several types of cancer, including CC, and is considered a promising therapeutic target.17 Several studies indicated that ERK5-dependent NF-κB activation is important for survival in mitosis, cell cycle progression and tumour xenograft growth.6, 12, 18, 19